We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
INVO | INVO BioScience Inc | 3.04 | 2.28 | 300.00% | 190,050,603 |
EDBL | Edible Garden AG Inc | 7.39 | 2.84 | 62.42% | 12,097,677 |
SINT | SiNtx Technologies Inc | 0.0319 | 0.009 | 39.30% | 397,543,198 |
GRTX | Galera Therapeutics Inc | 0.2285 | 0.0585 | 34.41% | 11,546,715 |
TCON | TRACON Pharmaceuticals Inc | 2.295 | 0.585 | 34.21% | 879,709 |
PXMD | PaxMedica Inc | 0.8798 | 0.2198 | 33.30% | 1,998,649 |
VNDA | Vanda Pharmaceuticals Inc | 5.315 | 1.27 | 31.23% | 21,381,581 |
VIRX | Viracta Therapeutics Inc | 0.926 | 0.2112 | 29.55% | 180,585 |
CEAD | CEA Industries Inc | 0.63 | 0.1403 | 28.65% | 153,592 |
WISA | WiSA Technologies Inc | 7.6801 | 1.58 | 25.90% | 53,359,264 |
BRKHU | BurTech Acquisition Corporation | 13.06 | 2.43 | 22.86% | 17 |
HONG KONG, April 17, 2024 /PRNewswire/ -- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"), announced today that it voluntarily requested a withdrawal of a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (File No.333-275708, the "Registration Statement") and accordingly cancelled the proposed public offering pursuant to the Registration Statement .
WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests and maximize value for all stockholders. The Rights Plan is effective immediately.
WiSA Association, a subsidiary of WiSA Technologies, Inc. (Nasdaq: WISA), announced today that it has executed its fourth 5-year WiSA E licensing agreement with a fourth major HDTV/PTV (Projection TV) brand. The WiSA E license allows the brand to integrate WiSA E software into its products, thereby offering consumers a variety of wireless immersive audio options including full interoperability with any of the WiSA E-enabled speakers offered by the many WiSA Association speaker brands.
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that an independent Data Monitoring Committee (DMC) has recommended continuing the pivotal Phase 3 RAISE trial evaluating intravenous (IV) ganaxolone for the treatment of refractory status epilepticus (RSE) following an interim analysis.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 61,746.50 | -2,097.46 | -3.29% | 1.21T | 6,869,468,334 |
ETH | Ethereum | 3,029.59 | -55.23 | -1.79% | 363.64B | 2,917,795,828 |
USDT | Tether USD | 0.99995 | -0.00005 | 0.00% | 97.83B | 466,941,796 |
BNB | Binance Coin | 536.70 | -1.44 | -0.27% | 84.81B | 434,953,277 |
SOL | Solana | 136.51 | 0.080 | 0.06% | 59.39B | 2,067,491,803 |
STETH | stETH | 3,023.85 | -40.42 | -1.32% | 29.59B | 15,370,439 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,172,808,437 |
XRP | Ripple | 0.4993 | 0.0026 | 0.52% | 27.22B | 419,963,275 |
DOGE | Dogecoin | 0.15025 | -0.0058 | -3.72% | 21.5B | 626,775,442 |
TONCOIN | Wrapped TON Coin | 6.19 | -0.164316 | -2.59% | 21.46B | 229,816,232 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions